搜索筛选:
搜索耗时3.9046秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
发布年度:
[期刊论文] 作者：Hidetaka Hamasaki,,
来源：World Journal of Diabetes 年份：2016
Physical activity improves glycemic control and reduces the risk of cardiovascular disease (CVD) and mortality in patients with type 2 diabetes (T2D). Moderate...
[期刊论文] 作者：Hidetaka Hamasaki,
来源：世界糖尿病杂志:英文版(电子版) 年份：2018
Exercise therapy is essential for the management of type 2 diabetes(T2D).However,patients with T2D show lower physical activity and reduced cardiorespiratory fi...
[期刊论文] 作者：Hidetaka Hamasaki,
来源：世界糖尿病杂志：英文版（电子版） 年份：2018
Recently,glucagon-like peptide-1(GLP-1)receptor agonists have become a cornerstone for the treatment of obese patients with type 2 diabetes(T2D),exhibiting favo...
[期刊论文] 作者：Hidetaka Hamasaki,
来源：结合医学学报（英文版） 年份：2017
Recent studies have shown exercise is associated with changes in the gut microbiota in humans as well as in experimental animals. Tai Chi is an exercise that in...
[期刊论文] 作者：Hidetaka Hamasaki,Shuichi Mish,
来源：世界糖尿病杂志：英文版（电子版） 年份：2012
Inflammation induces insulin resistance and hyperinsulinemia due to elevation of serum cytokines such as tumor necrosis factor-α and interleukins. Chronic myel...
Efficacy of anagliptin as compared to linagliptin on metabolic parameters over 2 years of drug consu
[期刊论文] 作者：Hidetaka Hamasaki,Yasuteru Ham,
来源：世界糖尿病杂志：英文版（电子版） 年份：2018
AIM To evaluate the comparative effectiveness of anagliptin and linagliptin on the clinical parameters in patients with type 2 diabetes mellitus(T2DM).METHODS A...
Hyperinsulinemia and insulin resistance in a patient with type 2 diabetes complicated with myelofibr
[期刊论文] 作者：Hidetaka Hamasaki,Shuichi Mishima,Hidekatsu Yanai,,
来源：World Journal of Diabetes 年份：2012
Inflammation induces insulin resistance and hyperinsulinemia due to elevation of serum cytokines such as tumor necrosis factor-α and interleukins. Chronic myel...
[期刊论文] 作者：Hidekatsu Yanai,Hiroki Adachi,Hisayuki Katsuyama,Sumie Moriyama,Hidetaka Hamasaki,Akahito Sako,,
来源：World Journal of Diabetes 年份：2015
Recent clinical trials indicated that the intensive glycemic control do not reduce cardiovascular disease mortality among diabetic patients, challenging a signi...
相关搜索：
